Literature DB >> 21633791

Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins.

Subhash Kharb1, Shiv Charan.   

Abstract

To investigate the effect of boosting immunity via mucosal route vis-a-vis parenteral route in the mouse model of haemorrhagic septicaemia, mice preimmunized with OMP of Pasteurella multocida (B:2) were immunized with 10(2) cfu of P. multocida via intranasal and subcutaneous routes. Mice were challenged through intranasal route (natural route of infection) with 10(8) cfu 14 days after immunization. Group of mice which were immunized intranasally showed significant protection (P < 0.05) of 88% as compared to 50% protection in group of mice immunized subcutaneously. In the control group of mice, 100% mortality occurred within 48 h. of challenge. The results of present study indicated that boosting of immunity via mucosal route in mice preimmunized with OMP provided better protection against P. multocida. This study may have implications for developing better vaccination strategies for the natural host.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633791     DOI: 10.1007/s11259-011-9484-8

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  8 in total

Review 1.  Pasteurella multocida pathogenesis: 125 years after Pasteur.

Authors:  Marina Harper; John D Boyce; Ben Adler
Journal:  FEMS Microbiol Lett       Date:  2006-12       Impact factor: 2.742

Review 2.  Mucosal vaccines: the promise and the challenge.

Authors:  Marian R Neutra; Pamela A Kozlowski
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.

Authors:  J Christopher Hodgson; Anna Finucane; Mark P Dagleish; Saeed Ataei; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG.

Authors:  H Martin Vordermeier; Kris Huygen; Mahavir Singh; R Glyn Hewinson; Zhou Xing
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine.

Authors:  A Myint; T O Jones; H H Nyunt
Journal:  Vet Rec       Date:  2005-01-08       Impact factor: 2.695

7.  Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.

Authors:  Jun Wang; Lisa Thorson; Richard W Stokes; Michael Santosuosso; Kris Huygen; Anna Zganiacz; Mary Hitt; Zhou Xing
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

8.  Relationship between the iron regulated outer membrane proteins and the outer membrane proteins of in vivo grown Pasteurella multocida.

Authors:  K Choi-Kim; S K Maheswaran; L J Felice; T W Molitor
Journal:  Vet Microbiol       Date:  1991-06       Impact factor: 3.293

  8 in total
  11 in total

1.  Mouse model of haemorrhagic septicaemia: dissemination and multiplication of Pasteurella multocida B:2 in vital organs after intranasal and subcutaneous challenge in mice.

Authors:  Subhash Kharb; Shiv Charan
Journal:  Vet Res Commun       Date:  2012-12-14       Impact factor: 2.459

2.  Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.

Authors:  Jin Hur; Hoyeon Byeon; John Hwa Lee
Journal:  Can J Vet Res       Date:  2014-10       Impact factor: 1.310

3.  Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens.

Authors:  Arunee Thanasarasakulpong; Pichayanut Poolperm; Pallop Tankaew; Takuo Sawada; Nattawooti Sthitmatee
Journal:  J Vet Med Sci       Date:  2014-12-20       Impact factor: 1.267

Review 4.  Nanoparticle-Based Vaccines Against Respiratory Viruses.

Authors:  Soultan Al-Halifa; Laurie Gauthier; Dominic Arpin; Steve Bourgault; Denis Archambault
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

5.  The Enhancement of the Pasteurella's Bacterin by Propolis Extracts.

Authors:  Tarek Adnan Ahmad; Samar Saeed Rammah; Salah Ahmed Sheweita; Medhat Haroun; Laila Hamdy El-Sayed
Journal:  Rep Biochem Mol Biol       Date:  2018-04

Review 6.  Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Authors:  Amir Seyfoori; Mahdieh Shokrollahi Barough; Pooneh Mokarram; Mazaher Ahmadi; Parvaneh Mehrbod; Alireza Sheidary; Tayyebeh Madrakian; Mohammad Kiumarsi; Tavia Walsh; Kielan D McAlinden; Chandra C Ghosh; Pawan Sharma; Amir A Zeki; Saeid Ghavami; Mohsen Akbari
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

7.  Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models.

Authors:  Ae Jeong Kwon; Ja Young Moon; Won Kyong Kim; Suk Kim; Jin Hur
Journal:  J Vet Med Sci       Date:  2016-06-25       Impact factor: 1.267

8.  Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.

Authors:  Korkiat Muangthai; Pallop Tankaew; Thanya Varinrak; Ratchanee Uthi; Suvichai Rojanasthien; Takuo Sawada; Nattawooti Sthitmatee
Journal:  J Vet Med Sci       Date:  2017-11-06       Impact factor: 1.267

9.  An Intranasal Vaccination with a Recombinant Outer Membrane Protein H against Haemorrhagic Septicemia in Swamp Buffaloes.

Authors:  Anucha Muenthaisong; Boondarika Nambooppha; Amarin Rittipornlertrak; Pallop Tankaew; Thanya Varinrak; Korkiat Muangthai; Kheemchompu Atthikanyaphak; Takuo Sawada; Nattawooti Sthitmatee
Journal:  Vet Med Int       Date:  2020-05-26

Review 10.  Nanomedicine strategies to target coronavirus.

Authors:  Marcel Alexander Heinrich; Byron Martina; Jai Prakash
Journal:  Nano Today       Date:  2020-08-31       Impact factor: 18.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.